Tanvir Khaliq

Tanvir Khaliq is an Assistant Professor at South Dakota State University (SDSU), affiliated with the College of Pharmacy and Allied Health Professions and the Department of Pharmaceutical Sciences. He holds a Ph.D. in Medicinal Chemistry from the Central Drug Research Institute, followed by postdoctoral training at the University of Washington, University of Kansas, and University of Florida. His research focuses on anti-parasitic drug discovery (leishmaniasis, malaria), opioid pain/drug abuse mechanisms, and developing cost-effective screening methods for newborns' metabolic disorders. He teaches medicinal chemistry in pharmacy and graduate programs and chairs SDSU committees like the Faculty Development Committee and Pharm.D. Accreditation Committee.

Dr. Khaliq's research employs medicinal chemistry and pharmacokinetic approaches to design novel compounds, including quinazoline alkaloids and macrocyclic peptides. His work has led to patents for newborn screening methods and grants from the South Dakota Board of Regents and National Institute on Aging. Notable awards include the American Chemical Society's Medicinal Chemistry Award and travel grants from the International Narcotic Research Committee.

Key contributions include identifying orally active antiparasitic agents against drug-resistant strains and advancing kappa opioid receptor ligands for pain management. His publications span drug design, enzyme screening technologies, and natural product-derived therapeutics, reflecting his interdisciplinary expertise in organic synthesis, pharmacology, and translational medicine.